Show Notes
MacGregor et al., The American Journal of Human Genetics - Pathogenic TP53 variants found in blood have long been read as inherited Li-Fraumeni alleles, but many turn out to be somatic clones that grew with age. Using whole-exome data from 469,391 UK Biobank participants, this study combines variant allele fraction with haplotype sharing to tell the two origins apart, and finds that in cancer-free middle-aged adults the risk is mostly somatic and mostly hematological. Key terms: TP53, clonal hematopoiesis, Li-Fraumeni syndrome, UK Biobank, variant classification.
Study Highlights:
Rare coding TP53 variants were called in 469,391 UK Biobank participants aged 40 to 70, and 1,753 nonsynonymous variants were sorted by variant allele fraction combined with haplotype sharing across individuals carrying the same allele. Of 55 unique pathogenic TP53 variants detected, only six were classified as germline, and most of those sit at positions linked to partial rather than complete loss of p53 function. Classic Li-Fraumeni alleles behaved like somatic clonal expansions: their prevalence rose with age at an odds ratio of 2.3 per decade, while likely germline variants showed no age trend. Incident cancer risk separated sharply by origin, with the signal for somatic and inconclusive variants driven almost entirely by blood cancers rather than solid tumors, reaching a hazard ratio of 16.5 for the high-allele-fraction inconclusive class. The prevalence of somatic expansion tracked missense pathogenicity, suggesting that clonal growth in blood is itself an in vivo readout of how much a variant damages p53.
Conclusion:
In a population cohort of healthy middle-aged adults, most apparently pathogenic TP53 variants detected in blood reflect somatic clonal expansion rather than inherited predisposition, and the cancer risk they carry is predominantly hematological. Distinguishing the two origins with allele fraction and shared haplotypes gives a scalable way to interpret TP53 variants outside the clinic, where classic Li-Fraumeni assumptions do not hold.
Music:
Enjoy the music based on this article at the end of the episode.
Article title:
Shared inheritance reveals landscape of somatic and germline cancer risk in TP53
First author:
MacGregor
Journal:
The American Journal of Human Genetics
DOI:
10.1016/j.ajhg.2026.07.011
Reference:
MacGregor, H.A.J., Blundell, J.R., and Easton, D.F. (2026). Shared inheritance reveals landscape of somatic and germline cancer risk in TP53. The American Journal of Human Genetics 113, 1916-1928. https://doi.org/10.1016/j.ajhg.2026.07.011
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:
❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01
☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase
More at basebybase.com
On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/tp53-somatic-germline-cancer-risk-biobank
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2026-09-10.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the scientific body from the TP53 and Li-Fraumeni background through clonal hematopoiesis, the allele-fraction and haplotype-sharing methodology, the classification results, the incident cancer risk analysis, the somatic-expansion-as-functional-proxy argument, and the stated limitations.
- transcript topics: TP53 function and Li-Fraumeni syndrome penetrance; Clonal hematopoiesis and somatic clonal expansion in bone marrow; Variant allele fraction and why it fails alone at high VAF; Haplotype sharing and identity by descent via GERMLINE2; Classification split of pathogenic TP53 variants in UK Biobank; Incident cancer risk by variant origin, hematological versus solid
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- 315 individuals carrying pathogenic or likely pathogenic TP53 variants
- 87% of pathogenic TP53 variants classified by the combined method
- 70% somatic, 17% germline, 13% inconclusive
- Minimum shared haplotype segment length of 1.5 cM
- Hazard ratio 16.5 for hematological cancer in the inconclusive group
- No prospective hematological cancers among germline carriers
QC result: Pass.
